Compare Nordic American Tankers Limited Common Stock (NAT) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nordic American Tankers Limited Common Stock vs Revvity Inc — how do they compare? Nordic American Tankers Limited Common Stock trades at $7.99 (market cap $1.74B), while Revvity Inc trades at $155 (market cap $16.97B). The key difference: Revvity Inc is far larger — about 9.8× Nordic American Tankers Limited Common Stock's market cap, and Nordic American Tankers Limited Common Stock pays the higher dividend (13.15%). Which is the better fit depends on your goals — on Pluang, investors hold Nordic American Tankers Limited Common Stock for 0 Days and Revvity Inc for 13 Days on average.
| NAT | RVTY | |
|---|---|---|
Market Cap | $1.74B | $16.97B |
Volume | 8,906,830 | 1,602,713 |
Sector | Industrials | Health |
52-Week High | $8.79 | $157.36 |
52-Week Low | $3.26 | $82.26 |
Typical Hold Time | 0 Days | 13 Days |
Enterprise Value | $2.01B | $19.29B |
Dividend Yield | 13.15% | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NAT trades at $8.79, matching its 52-week high, reflecting strong momentum amid favorable tanker market conditions. The stock shows robust fundamentals with a 33.34% net income margin and 25.66% ROE for 2026, while Q2 2026 EPS beat expectations. Technical indicators are neutral, with support and resistance clustered around $9. Recent news highlights surging spot rates and insider buying by the Hansson family, underscoring confidence in near-term prospects.
Outlook is positive due to elevated freight rates and earnings growth, but risks include volatility in tanker rates and geopolitical tensions. Analysts are mixed with a $3.50 consensus target, suggesting caution despite operational strength. The stock's high yield and momentum offer appeal, though sustainability of current rates remains a key monitorable.
RVTY trades at $155.08, down 0.34% today but near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving average support. Recent earnings beats and a Zacks upgrade to Buy reflect positive momentum. The company launched a new Type 1 diabetes screening kit in Europe and announced the acquisition of Human Cell Design, expanding its metabolic disease research tools.
Outlook remains positive with revenue stability and margin pressures manageable. Investment opportunity lies in diagnostic growth and AI-driven demand, though premium valuation and China market risks warrant caution. The absence of sell ratings and strong institutional accumulation support a constructive view, but rich multiples require sustained earnings delivery for further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nordic American Tankers Limited Common Stock
Nordic American Tankers Limited is a Bermuda-based shipping company specializing exclusively in Suezmax crude-oil tankers, which it charters in the spot and period markets on international routes. The company has paid a dividend every quarter since 1997.
Read more on NAT →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
